Application of standardization for the design and construction of carbon nanotube-based product pilot lines in compliance with EU regulation on machinery

The "PLATFORM" manufacturing ecosystem for pilot production of pre-commercial CNT-based nano-enabled products, consists of three pilot lines (PPLs) for the manufacture of buckypapers, doped prepregs and doped veils. The PPLs have been constructed with the ultimate goal to commercialize these products in the European market in 2020/2022.This goal requires having the PPLs in compliance with the applicable product safety regulation by that date (CE marking). The main EU regulation for new machinery (as the PPLs) is the Directive 2006/42/EC on Machinery (MD). This Directive sets out the general mandatory Essential Health and Safety Requirements (EHSRs) related to the design and construction of machinery, while particular technical specifications for fulfilling them are provided in European harmonized standards. Application of harmonized standards is voluntary but confers a presumption of conformity with the EHSRs they cover. The PPLs are unique machines for own use and must comply with the MD before they are put into service, in 2020/2022. But the MD does not provide specific EHSRs for nanosafety and no harmonized standards are available in this field for the safe design of the PPLs. In this context, this paper shows the standardization strategy followed by the project PLATFORM (GA 646307) to design the PPLs in compliance with the EHSR referred to the risks to health resulting from hazardous substances emitted by machinery (MD, Annex I, EHSR 1.5.13). In the absence of nanosafety harmonized standards to satisfy the aforementioned EHSR, the design and design verification of the PPLs were carried out through A & B - type harmonized standards (e.g. EN ISO 12100, EN ISO 14123-1/2), and other European and international standards.The projects PLATFORM and OASIS have received funding from the European Union’s Horizon 2020 research and innovation programme, under grant agreements Nº 646307 and Nº 814581, respectively. This paper reflects only the authors’ views, and the Commission is not responsible for any use that may be made of the information contained therein

Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

The original version of this article unfortunately contained a mistake

Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

Exposure Assessment During the Industrial Formulation and Application of Photocatalytic Mortars Based on Safer n-TiO2 Additives

Titanium dioxide nanoparticles (n-TiO2) are added to photocatalytic mortars to improve urban air quality. Their activity can be increased by dispersing and binding them on natural sepiolite surface. Workers handling photocatalytic additives can be exposed to n-TiO2. However, the release of nanoparticles to the workplace can be different if the material used is raw n-TiO2 powders or if the nanoparticles are supported on sepiolite. In this work, we compare occupational exposure to n-TiO2 for raw n-TiO2 and a hybrid additive n-TiO2/sepiolite obtained by a proprietary process. Measurements were performed in two industrial sites that process 1 ton batches of mortars, formulated with the same quantity of n-TiO2, followed by their application outdoors. Direct reading instruments were used to monitor particle number concentration and size distribution. Simultaneously, filter-based samples were collected for mass concentration and microscopy analysis. Two tasks produced a significant release of particles, the addition of fillers during the mortar formulation, in site 1, and the mixing of mortar with water for its application in the second site. For the first task, particle concentration was significantly lower when the n-TiO2/sepiolite was added compared to the raw n-TiO2. For the second task, once the mortar is fully formulated, this metric does not identify differences among the batches. Titanium mass concentration was 3–10 times lower when handling the mortar formulated with the hybrid additive. These results suggest that supporting the n-TiO2 on the sepiolite network not only increases the photocatalytic activity, but is also a safer design that reduces exposure to nanoparticles.FP7 280535 (SCAFFOLD

Biomedical applications of polymeric biomaterials

Polymer biomaterials have had an unfavourable image due to their association with pollution. However, they are important in biomedicine. Polymers are versatile materials, they can be obtained in several chemical configurations and mixtures to generate composite materials with synergistic properties. In this research, a scientific and technological analysis of the biomedical application of polymeric biomaterials was performed, along with the compilation of their applications, production, mechanical properties and important features for the biomedical industry. Polymeric biomaterials area cutting-edge topic, as reflected in the number of scientific articles and patents. Nowadays, these biomaterials canreplace, reinforce or fulfil a specific function in the human body. However, due to the complexity of biological systems, immune reactions are still present,preventingthe development of tissues and functional organs in laboratory scale.Los materiales poliméricos han tenido una imagen desfavorable, ya que son asociados con contaminación. Sin embargo,estos son de gran importancia para la biomedicina. Los polímeros son materiales muy versátiles, se pueden obtener de múltiples configuraciones químicas y mezclaspara generar materiales compuestos conpropiedades sinérgicas. En esta investigaciónse realizó un análisis científico y tecnológico de las aplicaciones biomédicas de biomateriales poliméricos y se recopila algunas de sus aplicaciones, propiedades mecánicas y características importantes para la industria biomédica. Los biomateriales poliméricos sonuna temática de punta como se refleja en el número de artículos científicios y de patentes. En la actualidad, estos biomateriales pueden llegar a reemplazar, reforzar o cumplir una función específica en el cuerpo humano. No obstante, debido a la complejidad de los sistemas biológicos aún se siguen presentando reacciones inmunes,que evitan el desarrollo de tejidos u órganos funcionales a escala de laboratorio

Aplicaciones biomédicas de biomateriales poliméricos

Los materiales poliméricos han tenido una imagen desfavorable, ya que son asociados con contaminación. Sin embargo, estos son de gran importancia para la biomedicina. Los polímeros son materiales muy versátiles, se pueden obtener de múltiples configuraciones químicas y mezclas para generar materiales compuestos con propiedades sinérgicas. En esta investigación se realizó un análisis científico y tecnológico de las aplicaciones biomédicas de biomateriales poliméricos y se recopila algunas de sus aplicaciones, propiedades mecánicas y características importantes para la industria biomédica. Los biomateriales poliméricos son una temática de punta como se refleja en el número de artículos científicios y de patentes. En la actualidad, estos biomateriales pueden llegar a reemplazar, reforzar o cumplir una función específica en el cuerpo humano. No obstante, debido a la complejidad de los sistemas biológicos aún se siguen presentando reacciones inmunes, que evitan el desarrollo de tejidos u órganos funcionales a escala de laboratorio.Polymer biomaterials have had an unfavourable image due to their association with pollution. However, they are important in biomedicine. Polymers are versatile materials, they can be obtained in several chemical configurations and mixtures to generate composite materials with synergistic properties. In this research, a scientific and technological analysis of the biomedical application of polymeric biomaterials was performed, along with the compilation of their applications, production, mechanical properties and important features for the biomedical industry. Polymeric biomaterials are a cutting-edge topic, as reflected in the number of scientific articles and patents. Nowadays, these biomaterials can replace, reinforce or fulfil a specific function in the human body. However, due to the complexity of biological systems, immune reactions are still present, preventing the development of tissues and functional organs in laboratory scale

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN

Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat